DZ Bank has increased its price goal for argenx to 935 EUR from 861 EUR.

ARGX · argenx

The AI's read

VYVGART sales beating analysts’ expectations suggests argenx’s main therapy is selling well. DZ Bank raised its estimate and kept its rating unchanged. The report follows recent quarterly results, so it adds no new sales figures.